Anti-thymocyte globulin (ATG) dose of 4.5 mg/kg vs 7.5 mg/kg did not result in a significant difference in the incidence of moderate to severe chronic graft vs host disease in allogeneic hematopoietic stem cell transplantation (HSCT) from unrelated donor